There has been increased interest and research in psychedelics as a treatment for mental illness in recent years. A new review study concludes that while research is still preliminary, psychedelics, such as lysergic acid diethylamide (LSD), show promise for treating conditions including treatment-resistant depression, anxiety and posttraumatic stress disorder (PTSD).
With COVID-19 evolving rapidly across the world, APA’s Committee on Psychiatric Dimensions of Disasters and the APA’s Council on International Psychiatry compiled the following list of resources for psychiatrists.
Rumination involves repetitive thinking or dwelling on negative feelings and distress and their causes and consequences. The repetitive, negative aspect of rumination can contribute to the development of depression or anxiety and can worsen existing conditions.
Infectious disease outbreaks, such as the novel coronavirus (COVID-19), create significant distress for the public and strain health care systems tasked with caring for affected individuals and containing the disease. Fear and uncertainty heavily influence public behaviors.
An estimated 15% of children and adolescents will be diagnosed with a mental disorder before age 18, according to a new study published in JAMA Psychiatry last month.